← OptimizeRx Corp OPRX
Market Price
$8.73
Market Cap
$164.76M
P/E Ratio
32.33
Revenue (FY 2025)
↑18.8% YoY
$109.43M
3-Yr CAGR: 374.4%
Net Income
↑125.5% YoY
$5.13M
Net Margin: 4.7%
Free Cash Flow
↑290.6% YoY
$18.66M
FCF Yield: 11.32%
EPS (Diluted)
↑124.5% YoY
$0.27
Basic: $0.28
Return on Equity
Efficiency
4.0%
ROA: 7.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (OPRX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $7.8M | — | $4.3M | $-1.5M | — | — | — | $-0.5M | $-0.6M | — |
| FY 2017 | $8.4M | +8.8% | $5.2M | $-2.1M | -36.7% | $-0.21 | — | $-1.5M | $-1.5M | -136.2% |
| FY 2018 | $21.2M | +151.5% | $12.2M | $0.2M | +110.8% | $0.02 | +109.5% | $0.8M | $0.8M | +149.8% |
| FY 2019 | $24.6M | +16.0% | $15.4M | $-3.1M | -1,488.4% | $-0.23 | -1,250.0% | $-1.7M | $-1.7M | -330.6% |
| FY 2020 | $43.3M | +76.1% | $24.1M | $-2.2M | +29.8% | $-0.15 | +34.8% | $-6.3M | $-6.4M | -264.8% |
| FY 2021 | $61.3M | +41.5% | $35.6M | $0.4M | +117.1% | $0.02 | +113.3% | $0.7M | $0.6M | +109.8% |
| FY 2022 | $1.0M | -98.3% | $0.6M | $-11.4M | -3,125.4% | $-0.64 | -3,300.0% | $10.7M | $10.6M | +1,589.8% |
| FY 2023 | $71.5M | +6,877.7% | $42.9M | $-17.6M | -53.6% | $-1.03 | -60.9% | $-7.2M | $-7.3M | -169.3% |
| FY 2024 | $92.1M | +28.8% | $59.4M | $-20.1M | -14.5% | $-1.10 | -6.8% | $4.9M | $4.8M | +165.2% |
| FY 2025 | $109.4M | +18.8% | $73.6M | $5.1M | +125.5% | $0.27 | +124.5% | $18.7M | $18.7M | +290.6% |
Valuation
Market Price
$8.73
Market Cap
$164.76M
Enterprise Value
$167.07M
P/E Ratio
32.33
P/B Ratio
1.28
FCF Yield
11.32%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
67.25%
Operating Margin
10.69%
Net Margin
4.69%
Return on Equity (ROE)
4.00%
Return on Assets (ROA)
7.93%
Asset Turnover
1.69x
Revenue 3-Yr CAGR
374.39%
Financial Health & Liquidity
Current Ratio
5.58
Cash Ratio
2.02
Debt / Equity
0.200
Debt / Assets
0.397
Cash & Equivalents
$23.36M
Total Debt
$25.68M
Book Value / Share
$6.84
Cash Flow Efficiency
Operating Cash Flow
$18.71M
Capital Expenditures (CapEx)
$58.00K
Free Cash Flow
$18.66M
OCF / Revenue
17.10%
FCF / Revenue
17.05%
FCF 3-Yr CAGR
20.84%
Per Share Metrics
EPS (Diluted)
$0.27
EPS (Basic)
$0.28
Dividends / Share
N/A
Book Value / Share
$6.84
EPS YoY Growth
124.55%
Balance Sheet (FY 2025)
Total Assets
$64.72M
Total Liabilities
$11.59M
Stockholders' Equity
$128.29M
Current Assets
$64.72M
Current Liabilities
$11.59M